Our mission is to develop a superior vaccine platform to improve clinical outcomes for cancer patients
Irazu Oncology has raised $500K in total funding. The most recent round was Seed. The last funding was announced in March 2025.
Irazu Oncology's investors include TEDCO.
Irazu Oncology is headquartered in Baltimore, United States.
Our mission is to develop a superior vaccine platform to improve clinical outcomes for cancer patients
Irazu Oncology is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Irazu Oncology — Funding & Investors." VCBacked, March 5, 2025, https://www.vcbacked.co/company/irazu-oncology. Accessed July 19, 2026.
VCBacked. (2025). Irazu Oncology — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/irazu-oncology
{{cite web |title=Irazu Oncology — Funding & Investors |url=https://www.vcbacked.co/company/irazu-oncology |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated